Medication Safety Officers Society
4010 Members Strong A society of healthcare professionals dedicated to improving medication safety in healthcare organizations
Our organization is working through the Sentinel Event Alert surrounding direct oral anticoagulants. I am curious to see what process improvement metrics other organizations are using to improve the safety of DOACs.
Hello,
I have been asked to research what other institutions use for sedation for cardioversion? Do you use a hypnotic agent? Do you have anesthesia involved?
Thanks
We are interested in how other organizations handle the CMS/TJC/CIHQ requirement that "processes and mechanisms should e established to monitor patient responses to a newly added medication before the medication is made available for dispensing or administration within the hospital."
Do you have a blanket statement in policy that is applicable to every new drug, or do you define individual parameters for each new drug? If you would be willing to share policies that would be very helpful.
To prevent wrong dose or wrong route administration errors when administering EPINEPHrine for anaphylaxis, has your organization employed either of the following safeguards:
1.)EPINEPHrine autoinjectors (e.g. EpiPen, EpiPen Jr, Auvi-Q)
a.) If yes, are there specific care areas where these items
are maintained as floorstock? (e.g. oncology, radiology)
To prevent wrong dose or wrong route administration errors when administering EPINEPHrine for anaphylaxis, has your organization employed either of the following safeguards:
1.)EPINEPHrine autoinjectors (e.g. EpiPen, EpiPen Jr, Auvi-Q)
a.) If yes, are there specific care areas where these items
are maintained as floorstock? (e.g. oncology, radiology)
Hello,
We are a pediatric institution and are looking for strategies on using texium tubing for doses <1.3 mL. With the 1.3 mL priming volume required (vs. 0.7 mL's for standard tubing) it is too long for these small doses. Any suggestions? Has anyone reported this concern to BD?